Anti-Human NGcGM3 Therapeutic Antibody (Racotumomab)
Recombinant Mouse antibody to Human NGcGM3. Racotumomab (trade name Vaxira) is a therapeutic cancer vaccine for the treatment of solid tumors. It induces the patient's immune system to generate a response against a cancer-specific molecular target with the purpose of blocking tumor growth, slowing disease progression and ultimately increasing patient survival.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-H58 |
| Pricing | Inquiry |
| Host | Mouse |
| Target | NGcGM3 |
| Species Reactivity | Human |
| Type | IgG1 - kappa |
| Applications | Inhib, Agonist, Cyt, ELISA |